查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800841

2025 年至 2033 年基因组学市场报告（按组件、应用、技术、最终用户和地区划分）

Genomics Market Report by Component, Application, Technology, End-User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球基因体学市场规模达 384 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 1,133 亿美元，2025-2033 年期间的复合年增长率 (CAGR) 为 12.77%。市场的主要成长动力是新一代定序 (NGS) 在癌症等慢性疾病中越来越多地用于检测基因异常，以及需要基因组定序的遗传和病毒性疾病的盛行率上升。此外，基因组学领域尖端技术的引入正在增强应用和研究。再者，个人化医疗的使用日益增多，推动了对基于基因组资讯的客製化治疗方案的需求，从而改善了患者的治疗效果。

基因组学市场分析：

  • 主要市场驱动因素：2025年基因组学市场规模将持续成长，这得益于基因定序技术的进步以及人们对个人化医疗日益增长的兴趣。研发投入至关重要，将推动基因组学市场价值的上升。
  • 主要市场趋势：人工智慧 (AI) 和机器学习 (ML) 在基因组学中的融合是基因组学市场的关键趋势，有助于提升基因组学市场的研究能力。这一趋势有助于完善预测模型，从而实现精准的基因组学市场预测。 CRISPR 基因编辑技术的采用凸显了治疗应用的重大转变，直接影响基因组学市场的需求。
  • 地理趋势：北美凭藉其先进的医疗基础设施以及对研究和创新的高度重视，在基因组学市场收入方面占据主导地位。受政府措施不断增加以及基因组学研究日益受到重视的推动，亚太地区的基因组学市场成长率最高。这项扩张提供了多样化的基因组学市场概况，预示着不同地区存在不同的成长前景。
  • 竞争格局：基因组学领域的知名市场参与者包括Illumina公司、赛默飞世尔科技、凯杰公司、安捷伦科技、牛津奈米孔技术公司和CRISPR Therapeutics等。这些实体对于基因组学市场前景至关重要，其竞争策略和创新为市场收入做出了巨大贡献。
  • 挑战与机会：与基因资料相关的伦理问题以及基因组定序的高昂成本为基因组学市场带来了挑战。然而，这些挑战也为满足日益增长的基因组学市场需求带来了创新机会。开发经济高效的定序方法并制定伦理准则，可以进一步提升基因组学市场的价值，并促进基因组学市场的成长。

基因组学市场趋势：

定序技术的技术创新

根据基因组学市场分析，创新技术的快速进步，尤其是新一代定序 (NGS) 和 CRISPR-Cas9 基因组改造创新，是基因组学市场的重要驱动力。新兴新创公司为诊断、个人化医疗和研究等多种用途提供定序服务。 NGS 等先进技术极大地改进了基因组分析，使其更快、更精确、更经济。政府和产业资金对于市场成长、支持研究工作和创新技术商业化也至关重要。例如，23andMe（一家在消费者基因检测领域占据领先地位的公司）和 Genome Medical（最近获得 1400 万美元资金以增强其远距医疗基因咨询服务）等例子，凸显了基因组学与医疗服务日益融合的趋势。这些进步有助于使基因组学更易于获取和使用，从而使 2025 年全球基因组学市场规模实现显着增长。

个人化医疗需求不断成长

推动市场发展的另一个重要驱动力是全球对个人化医疗日益增长的需求，个人化医疗是指根据每位患者的独特特征量身定制医疗方案。个人化医疗在很大程度上依赖基因资料，以便根据个人基因组成製定特定的疗法，从而摆脱传统医学的泛泛之谈，转向更精准、更有效的治疗方案。这也有助于提高消费者的认知度，帮助他们找到「基因组学市场是什么？」这个问题的答案。此外，人们对疾病遗传病因的认识和了解不断加深、遗传性疾病的发生率不断上升，以及传统疗法对各种疾病的局限性，也推动了需求的不断增长。在个人化医疗中运用基因组学旨在透过优先预防和精准治疗来改善患者的治疗效果，并提供经济高效的医疗保健方案，从而推动基因组学领域的更多投资和研究。

临床应用和诊断的扩展

基因组学技术在临床应用和诊断领域的应用日益广泛，例如识别遗传疾病、癌症筛检和监测传染病，也推动了市场的成长。对疾病遗传基础的深入了解使得基因组学能够融入临床护理，从而催生出新的诊断工具和基因检测，用于预测个体患特定疾病的风险、指导治疗选择并追踪疾病进展。不禁要问：基因体学的需求究竟有多大，尤其是在临床应用与诊断领域？基因组学技术的进步预计将继续推动该领域的需求，拓展其在液体活检和非侵入性产前检测 (NIPT) 等诊断领域的潜力，凸显基因组学在医疗保健和诊断领域革新中的关键作用。

基因组学市场细分：

按组件细分：

  • 产品
    • 仪器和软体
    • 耗材和试剂
  • 服务
    • 核心基因组学服务
    • 基于NGS的服务
    • 生物标誌物翻译服务
    • 计算服务
    • 其他的

耗材和试剂占据大部分市场份额

耗材和试剂产业因其在DNA定序、基因编辑和样品製备等各种基因组学程序中发挥的重要作用而占据市场主导地位。随着基因组学在医疗保健、农业和生物技术等领域的应用日益广泛，对特定耗材和试剂的需求也日益增长，促使製造商不断增强和扩展其产品范围。这促进了耗材产业的发展，凸显了其在推动和应用基因组学技术方面的关键作用，为市场的整体成长做出了重大贡献。此外，这些产品对于确保研究和临床诊断中基因组分析的准确性和可靠性至关重要，市场对这些产品的强劲需求进一步巩固了该行业的主导地位。

按应用分类：

  • 功能基因体学
  • 表观基因组学
  • 生物标记发现
  • 通路分析
  • 其他的

功能基因组学占据行业最大份额

功能基因组学专注于研究基因功能和相互作用，已成为市场主导领域，展现了其在理解复杂生物过程和疾病机制方面的关键作用。功能基因组学利用RNA定序和CRISPR-Cas9等高通量技术，能够深入研究基因表现和调控，进而推动生物医学研究和医疗保健领域的进步。此外，随着技术快速进步，人们对探索基因组功能特征的日益重视，使功能基因组学成为推动整个市场成长和创新的主要力量。

按技术划分：

  • 定序
  • 微阵列
  • 聚合酶炼式反应
  • 核酸萃取与纯化
  • 其他的

测序代表着领先的细分市场

定序技术是市场的主要组成部分，因为它在解读DNA和RNA中的遗传讯息方面发挥着至关重要的作用，使其成为最大的技术领域。定序技术能够揭示遗传变异和突变，从而提供关键洞见，推动其在个人化医疗、遗传研究和诊断应用领域中占据重要地位。此外，新一代定序（NGS）技术的兴起也正在改变这一领域，它比传统技术拥有更快的速度、更高的准确性和更高的成本效益。新一代定序技术能够对基因组、外显子组和转录组进行详细分析，进而推动对复杂疾病、演化生物学和微生物基因体学的理解。

按最终用户分类：

  • 研究中心
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

製药和生物技术公司在市场上占据明显主导地位

製药和生技公司在市场中扮演着重要角色，强调其在推动药物开发和个人化医疗方面的重要性。这些领域应用基因组资料来确定药物的新标靶，了解疾病的遗传起源，并利用个人基因资料开发客製化治疗方案。例如，全球 DNA 定序和阵列技术的顶尖公司 Illumina Inc. 与范德堡大学医学中心 (VUMC) 旗下着名的临床和基因组资料公司 Nashville Biosciences, LLC 合作，揭晓了基因组发现联盟 (AGD) 的五个创始成员。该扩展协议旨在透过进行彻底的基因组学研究和建立高品质的临床基因组学资料库来加快治疗开发过程。 AbbVie、Amgen、AstraZeneca、Bayer 和 Merck 将集中资源资助 250,000 个样本的定序，并可使用这些资料来开发药物和改进疗法。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据基因组学最大市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是基因组学最大的区域市场。

北美凭藉其先进的医疗保健体系、雄厚的研发投入以及顶尖製药和生物技术公司的聚集，占据了最大的市场份额。此外，该地区在基因组学和生物资讯学领域的先进技术，以及这些因素，为基因组学领域的发展和进步创造了良好的环境。北美在全球市场的强势地位得益于学术和研究机构与产业界的密切合作，这促进了创新，并引领了影响全球基因组学实践和政策的趋势。

竞争格局：

市场研究报告还对市场竞争格局进行了全面分析，并提供了所有主要公司的详细资料。基因组学行业的一些主要市场参与者包括

  • 23andMe公司
  • 安捷伦科技公司
  • 拜耳公司
  • 华大基因集团
  • Bio-Rad 实验室公司
  • 丹纳赫公司
  • Illumina公司
  • 牛津奈米孔技术公司
  • 珀金埃尔默公司
  • Myriad Genetics公司
  • F.霍夫曼-罗氏有限公司
  • 赛默飞世尔科技公司

产业主要参与者正积极进行各种策略活动，以维护和巩固其市场地位。这些企业正在大力投资研发，以推出新的基因组技术、服务和解决方案，以满足客户不断变化的需求。合作、建立伙伴关係和进行收购是重要的策略，有助于他们提昇技术能力、进入新市场并获得新的基因组应用和智慧财产权。此外，这些顶尖公司正致力于改进其生物资讯系统，以管理和分析基因组定序产生的大量资料。这将有助于提供完整的解决方案，将基因组学发现转化为临床和农业领域的进步。

本报告回答的关键问题

  • 什么是基因组学市场
  • 基因组学市场有多大
  • 基因组学的市场预测是什么
  • 推动全球基因组学市场的关键因素有哪些
  • COVID-19 对全球基因组学市场有何影响
  • 全球基因组学市场按成分划分如何？
  • 根据应用，全球基因组学市场如何划分
  • 根据技术，全球基因组学市场如何划分
  • 根据最终用户，全球基因组学市场如何划分
  • 10.全球基因体学市场的关键区域有哪些？
  • 11. 全球基因体学市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 基因组学市场是什么？基因组学市场有多大？
  • 基因组学的市场预测如何？
  • 推动全球基因体学市场发展的关键因素有哪些？
  • COVID-19 对全球基因体学市场有何影响？
  • 根据组成部分，全球基因组学市场是如何分類的？
  • 根据应用，全球基因体学市场如何分布？
  • 根据技术，全球基因组学市场如何划分？
  • 根据最终用户，全球基因组学市场是如何分類的？
  • 全球基因组学市场的关键区域有哪些？
  • 全球基因组学市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球基因体学市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：按组成部分

  • 产品
    • 主要类型
      • 仪器和软体
      • 耗材和试剂
  • 服务
    • 主要类型
      • 核心基因组学服务
      • 基于NGS的服务
      • 生物标誌物翻译服务
      • 计算服务
      • 其他的

第七章：市场区隔：依应用

  • 功能基因体学
  • 表观基因组学
  • 生物标记发现
  • 通路分析
  • 其他的

第八章：市场区隔：依技术

  • 定序
  • 微阵列
  • 聚合酶炼式反应
  • 核酸萃取与纯化
  • 其他的

第九章：市场区隔：依最终用户

  • 研究中心
  • 医院和诊所
  • 製药和生物技术公司
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格指标

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A2246

The global genomics market size reached USD 38.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 113.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.77% during 2025-2033. The market's main growth drivers are the increasing use of next-generation sequencing (NGS) in chronic diseases like cancer to detect genetic abnormalities and the rise in the prevalence of hereditary and viral disorders that require genomic sequencing. Additionally, the introduction of cutting-edge technologies in the genomics sector is enhancing applications and research. Furthermore, patient outcomes are being improved by the growing use of personalized medicine, which is driving the need for customized treatment regimens based on genomic information.

Genomics Market Analysis:

  • Major Market Drivers: The genomics market size 2025 is experiencing growth driven by advancements in genetic sequencing technologies and an increasing interest in personalized medicine. Investments in R&D are pivotal, pushing the genomics market value upwards.
  • Key Market Trends: Artificial intelligence (AI) and machine learning (ML) integration in genomics refer to the key genomics market trends, enhancing genomics market research capabilities. This trend aids in refining predictive modeling, leading to precise genomics market forecasts. The adoption of CRISPR gene editing technology highlights a significant shift in therapeutic applications, directly influencing genomics market demand.
  • Geographical Trends: North America dominates in terms of genomics market revenue, due to its advanced healthcare infrastructure and a strong focus on research and innovation. The Asia-Pacific region shows the fastest genomics market growth rate, propelled by increasing government initiatives and a burgeoning focus on genomics research. This expansion offers a diverse genomics market overview, signaling varied growth prospects across different regions.
  • Competitive Landscape: Notable market players in the genomics sector include Illumina, Inc., Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Oxford Nanopore Technologies, and CRISPR Therapeutics, among others. These entities are crucial in determining the genomics market outlook, with their competitive strategies and innovations significantly contributing to the market revenue.
  • Challenges and Opportunities: Ethical concerns related to genetic data and the high costs associated with genomic sequencing pose challenges in the genomics market. Yet, these challenges also unveil opportunities for innovation to meet the increasing genomics market demand. Developing cost-effective sequencing methods and establishing ethical guidelines could further bolster the genomics market value and facilitate genomics market growth.

Genomics Market Trends:

Technological innovations in sequencing technologies

According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. The emergence of startups providing sequencing services for diverse uses, such as diagnostics, personalized medicine, and research. Sophisticated technologies like NGS have greatly improved genomic analysis, ensuring it is quicker, more precise, and economical. Government and industry funding are also vital in growing the market, aiding research efforts and the commercialization of innovative technologies. Examples like 23andMe, a prominent player in consumer genetic testing, and Genome Medical, which recently obtained $14 million in funding to enhance its telehealth genetic consultations, underscore the growing fusion of genomics and healthcare services. These advancements contribute to making genomics more attainable and usable, thereby making the global genomics market size 2025 experience significant growth.

Growing demand for personalized medicine

Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the "what is the genomics market?" question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.

Expansion in clinical applications and diagnostics

The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.

Genomics Market Segmentation:

Breakup by Component:

  • Products
    • Instruments and Software
    • Consumables and Reagents
  • Services
    • Core Genomics Services
    • NGS-Based Services
    • Biomarker Translation Services
    • Computational Services
    • Others

Consumables and reagents account for the majority of the market share

The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.

Breakup by Application:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others

Functional genomics holds the largest share of the industry

Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.

Breakup by Technology:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

Sequencing represents the leading market segment

Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.

Breakup by End-User:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest genomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.

North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include

  • 23andMe, Inc
  • Agilent Technologies, Inc.
  • Bayer AG
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Illumina, Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Myriad Genetics, Inc.
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.

Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.

Key Questions Answered in This Report

  • 1.What is the genomics market?
  • 2.How big is the genomics market?
  • 3.What is the market forecast for genomics?
  • 4.What are the key factors driving the global genomics market?
  • 5.What has been the impact of COVID-19 on the global genomics market?
  • 6.What is the breakup of the global genomics market based on the component?
  • 7.What is the breakup of the global genomics market based on the application?
  • 8.What is the breakup of the global genomics market based on the technology?
  • 9.What is the breakup of the global genomics market based on the end-user?
  • 10.What are the key regions in the global genomics market?
  • 11.Who are the key players/companies in the global genomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2024
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2024
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Genomics Market: Competitive Structure
  • Table 8: Global: Genomics Market: Key Players